Impact of resistance training on body composition and metabolic syndrome variables during androgen deprivation therapy for prostate cancer: a pilot randomized controlled trial

Table 8 Average daily dietary values during the 12-week intervention for all groups

	Baseline		Weeks 1–12
					TRAIN*PRO	EXE vs. NoEXE		PRO vs. NoPRO
Outcome	n	Mean ± SD	n	Mean ± SD	P ^†	Group difference in mean change (95% CI)	P ^*	Group difference in mean change (95% CI)	P ^**
Protein (g⋅day^− 1)					0.04	4.6 (−9.0, 18.1)	0.49	13.0 (0.1, 25.9)	0.048
TRAINPRO	8	93.9 ± 34.3	6	118.1 ± 30.2
TRAIN	8	74.2 ± 15.6	7	83.1 ± 13.9
PRO	10	85.5 ± 44.4	10	99.5 ± 38.6
STRETCH	9	76.5 ± 30.6	9	87.8 ± 33.7
Protein (g ·kg⁻¹·day⁻¹)					0.14	0.0 (−0.2, 0.2)	0.77	0.4 (0.1, 0.7)	0.01
TRAINPRO	8	1.1 ± 0.5	6	1.4 ± 0.5
TRAIN	8	1.1 ± 0.7	7	1.2 ± 0.6
PRO	10	0.9 ± 0.2	10	1.0 ± 0.2
STRETCH	9	1.0 ± 0.3	9	1.1 ± 0.6
Carbohydrates (g⋅day⁻¹)					0.12	37.4 (−1.8, 76.6)	0.06	−5.6 (−44.4, 33.2)	0.77
TRAINPRO	8	239.3 ± 78.6	6	217.8 ± 74.1
TRAIN	8	222.0 ± 94.8	7	243.1 ± 30.4
PRO	10	190.2 ± 65.2	10	184.6 ± 73.5
STRETCH	9	184.6 ± 57.4	9	162.0 ± 38.8
Total fat (g⋅day⁻¹)					0.82	5.1 (−7.9, 18.1)	0.43	−5.9 (−18.6, 6.8)	0.35
TRAINPRO	8	70.8 ± 55.4	6	77.8 ± 53.4
TRAIN	8	78.7 ± 27.6	7	77.4 ± 16.3
PRO	10	71.1 ± 19.1	10	63.1 ± 23.5
STRETCH	9	53.5 ± 12.9	9	61.1 ± 17.2
Total energy (kcal⋅day⁻¹)					0.73	107.0 (−85.4, 299.4)	0.27	−24.2 (− 251.1, 202.6)	0.83
TRAINPRO	8	1976 ± 708	6	2062 ± 753
TRAIN	8	1866 ± 636	7	1988 ± 193
PRO	10	1784 ± 447	10	1778 ± 479
STRETCH	9	1561 ± 284	9	1624 ± 330

Data presented as mean ± standard deviation. P, significance level; EXE, exercise groups (TRAINPRO and TRAIN); NoEXE, non-exercise groups (PRO and STRETCH); PRO, protein supplementation groups (TRAINPRO and PRO); NoPRO, non-protein supplementation groups (TRAIN and STRETCH)
^†Interaction effect of (TRAIN*PRO)
^*Main effect of EXE adjusted for baseline values
^**Main effect of PRO adjusted for baseline values

ISSN: 1471-2407